Results 81 to 90 of about 1,506,029 (346)

Total systems failure: police officers’ perspectives on the impacts of the justice, health, and social service systems on people who use drugs

open access: yesHarm Reduction Journal, 2022
Background Police in Canada have become main responders to behavioural health concerns in the community—a role that disproportionately harms people who use drugs (PWUD). Recent calls to defund the police emphasize the need to shift responsibility for non-
Amanda Butler, Naomi Zakimi, A. Greer
semanticscholar   +1 more source

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen   +7 more
wiley   +1 more source

Community contexts and knowledge: accountability, leadership and meaningful involvement of communities in Programme Science

open access: yesJournal of the International AIDS Society
Introduction A Programme Science approach that prioritizes populations who will benefit most and ensuring resources are allocated to programmes that meet the needs of those populations will bring an equity focus to research.
Ruth Morgan Thomas   +4 more
doaj   +1 more source

Considerations for equitable distribution of digital healthcare for people who use drugs. [PDF]

open access: yesBMC Health Serv Res
Abstract Background Telehealth holds the potential to expand healthcare access for people who use drugs (PWUD). However, approaches to increase PWUDs’ access to digital healthcare are not well-understood. We studied digital healthcare accessibility among PWUD.
Papalamprakopoulou Z   +8 more
europepmc   +5 more sources

Implementing a new HCV model of care for people who use drugs

open access: yesJHEP Reports
Background & Aims An estimated 50 million individuals have chronic hepatitis C virus (HCV) infection worldwide and people who use drugs (PWUD) are disproportionately affected.
Andrea Herranz Mochales   +14 more
semanticscholar   +1 more source

FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee   +7 more
wiley   +1 more source

(Re)politicizing harm reduction: Poststructuralist thinking to challenge the medicalization of harms among people who use drugs

open access: yesAporia, 2021
Poststructuralism, with its critical interpretations of knowledge, discourse, truth, and power, offers a set of compelling analytic tools for disentangling and deconstructing the ways in which health-related phenomena exist and are understood. This paper
Trevor Goodyear
doaj   +1 more source

HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. [PDF]

open access: yes, 2013
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is
Dillon, John   +40 more
core   +1 more source

Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis

open access: yesAddiction Science & Clinical Practice, 2022
Drug overdose rates in the United States have been steadily increasing, particularly in rural areas. The COVID-19 pandemic and associated mitigation strategies may have increased overdose risk for people who use drugs by impacting social, community, and ...
S. Walters   +10 more
semanticscholar   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy